Richard Pzena’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$824K Buy
45,310
+7,490
+20% +$133K ﹤0.01% 141
2026
Q2
$606K Buy
37,820
+9,460
+33% +$157K ﹤0.01% 142
2026
Q1
$525K Buy
28,360
+7,733
+37% +$136K ﹤0.01% 144
2025
Q4
$322K Buy
+20,627
New +$295K ﹤0.01% 146

Other funds holding TAK

Richard Pzena's TAK Position: Q3 2026 in Review

Richard Pzena increased its Takeda Pharmaceutical (TAK) stake by 20% in Q3 2026, buying an estimated $133K and bringing the position to 45,310 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #141.

Richard Pzena first reported a position in TAK in Q4 2025 and has held it in 4 quarters since. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Richard Pzena held 45,310 shares of Takeda Pharmaceutical worth $824K as of Q3 2026.
  • Richard Pzena bought 7,490 Takeda Pharmaceutical shares in Q3 2026, an estimated $133K.
  • Takeda Pharmaceutical made up ﹤0.01% of Richard Pzena's portfolio in Q3 2026, its #141 holding.
  • Richard Pzena first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
  • 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Pzena Investment Management's 13F filing for Q3 2026, filed 30 Oct 2026.